Omeros (OMER) Common Equity (2010 - 2026)
Omeros (OMER) reported Common Equity of -$63.3 million for Q1 2026, up 70.34% on a YoY basis from -$37.2 million in Q1 2025, and up 47.76% sequentially from -$121.2 million in Q4 2025.
Omeros (OMER) Common Equity (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Common Equity data on file, last reported at -$63.3 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 70.34% year-over-year to -$63.3 million; the trailing twelve-month figure through Mar 2026 stood at -$63.3 million (up 70.34% YoY), and the FY2025 full-year result was -$121.2 million, up 33.61% from the prior year.
- Common Equity improved to -$63.3 million in Q1 2026, from -$121.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $85.7 million in Q4 2022 to a low of -$228.7 million in Q2 2025.
- A 5-year average of -$78.9 million and a median of -$63.3 million in 2026 frame the typical range for Common Equity.
- Across the five-year window, Common Equity jumped 1215.45% in 2023 and tumbled 1005.02% in 2024, its largest moves.
- Tracing OMER's Common Equity over 5 years: stood at $85.7 million in 2022, then sank by 129.16% to -$25.0 million in 2023, then slumped by 630.93% to -$182.6 million in 2024, then soared by 33.61% to -$121.2 million in 2025, then soared by 47.76% to -$63.3 million in 2026.
- Business Quant data shows OMER's Common Equity at -$63.3 million in Q1 2026, -$121.2 million in Q4 2025, and -$220.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | -63.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.33 Mn |
| Dec 31, 2025 | -121.23 Mn |
| Sep 30, 2025 | -220.48 Mn |
| Jun 30, 2025 | -228.69 Mn |
| Mar 31, 2025 | -213.55 Mn |
| Dec 31, 2024 | -182.61 Mn |
| Sep 30, 2024 | -154.17 Mn |
| Jun 30, 2024 | -124.60 Mn |
| Mar 31, 2024 | -71.33 Mn |
| Dec 31, 2023 | -24.98 Mn |
| Sep 30, 2023 | -13.95 Mn |
| Jun 30, 2023 | 20.51 Mn |
| Mar 31, 2023 | 54.94 Mn |
| Dec 31, 2022 | 85.68 Mn |
| Sep 30, 2022 | -46.31 Mn |
| Jun 30, 2022 | -32.70 Mn |
| Mar 31, 2022 | -4.93 Mn |
| Dec 31, 2021 | 23.78 Mn |
| Sep 30, 2021 | -262.70 Mn |
| Jun 30, 2021 | -246.30 Mn |